Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Development of alpha-subsituted fosmidomycin analogues as antimalarial DOXP reductoisomerase inhibitors

Information

Project Team

Outputs and Outcomes

Promotor

Serge Van Calenbergh

Department of Pharmaceutics